JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NVEE
3476
DELISTED
NV5 Global
NVEE
| $1.74M | ﹤0.01% |
66,968
+12,660
| +23% | +$380K |
2017 Q3
22 quarters
|
|
3477
Vanguard Total Corporate Bond ETF
VTC
$1.64B
| $1.73M | ﹤0.01% |
+22,625
| New | +$1.72M |
2023 Q1
0 quarters
|
|
|
LGF.B
3478
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.73M | ﹤0.01% |
166,688
-66,925
| -29% | -$569K |
2016 Q4
25 quarters
|
|
3479
ANI Pharmaceuticals
ANIP
$1.66B
| $1.73M | ﹤0.01% |
43,539
+4,427
| +11% | +$187K |
2016 Q1
28 quarters
|
|
3480
Tompkins Financial
TMP
$1.39B
| $1.73M | ﹤0.01% |
26,109
+8,047
| +45% | +$592K |
2013 Q2
39 quarters
|
|
3481
BlackRock Floating Rate Income Strategies Fund
FRA
$366M
| $1.73M | ﹤0.01% |
147,485
+29,937
| +25% | +$351K |
2017 Q4
21 quarters
|
|
|
CONX
3482
DELISTED
CONX Corp. Class A Common Stock
CONX
| $1.73M | ﹤0.01% |
168,563
+563
| +0.3% | +$5.68K |
2020 Q4
9 quarters
|
|
3483
Kenon Holdings
KEN
$3.22B
| $1.72M | ﹤0.01% |
58,557
+41,217
| +238% | +$1.25M |
2021 Q1
8 quarters
|
|
3484
ProShares UltraPro S&P 500
UPRO
$5.58B
| $1.72M | ﹤0.01% |
44,498
+44,196
| +14,634% | +$1.61M |
2021 Q1
8 quarters
|
|
3485
Invesco KBW Bank ETF
KBWB
$6.13B
| $1.71M | ﹤0.01% |
40,812
-26,464
| -39% | -$1.38M |
2017 Q2
23 quarters
|
|
3486
CALL
CSX Corp
CSX
$87.1B
| $1.71M | ﹤0.01% |
57,100
+19,800
| +53% | +$609K |
2022 Q4
1 quarter
|
|
3487
ProShares S&P 500 ex-Health Care ETF
SPXV
$41.7M
| $1.71M | ﹤0.01% |
+40,000
| New | +$1.65M |
2023 Q1
0 quarters
|
|
3488
Consensus Cloud Solutions
CCSI
$657M
| $1.7M | ﹤0.01% |
49,980
+5,045
| +11% | +$243K |
2021 Q4
5 quarters
|
|
3489
GoodRx Holdings
GDRX
$1.12B
| $1.7M | ﹤0.01% |
272,251
+231,480
| +568% | +$1.29M |
2020 Q3
10 quarters
|
|
3490
Central Garden & Pet Co
CENT
$2.54B
| $1.7M | ﹤0.01% |
51,669
+4,859
| +10% | +$157K |
2015 Q4
29 quarters
|
|
3491
State Street SPDR S&P North American Natural Resources ETF
NANR
$806M
| $1.69M | ﹤0.01% |
+31,509
| New | +$1.71M |
2023 Q1
0 quarters
|
|
3492
CALL
Transocean
RIG
$5.96B
| $1.69M | ﹤0.01% |
265,800
+25,600
| +11% | +$164K |
2021 Q2
7 quarters
|
|
|
AVDX
3493
DELISTED
AvidXchange
AVDX
| $1.69M | ﹤0.01% |
216,496
-133,707
| -38% | -$1.29M |
2021 Q4
5 quarters
|
|
|
CSTR
3494
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.69M | ﹤0.01% |
111,471
-342,567
| -75% | -$5.72M |
2017 Q4
21 quarters
|
|
3495
PUT
NIO
NIO
$8.77B
| $1.68M | ﹤0.01% |
+160,000
| New | +$1.64M |
2023 Q1
0 quarters
|
|
3496
PUT
Cadence Design Systems
CDNS
$98.2B
| $1.68M | ﹤0.01% |
+8,000
| New | +$1.51M |
2023 Q1
0 quarters
|
|
3497
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.83B
| $1.68M | ﹤0.01% |
33,408
-52,507
| -61% | -$2.63M |
2020 Q1
12 quarters
|
|
|
TRTX
3498
TPG RE Finance Trust
TRTX
$451M
| $1.68M | ﹤0.01% |
231,338
-265,154
| -53% | -$2.11M |
2017 Q4
21 quarters
|
|
3499
CALL
The Kraft Heinz Company
KHC
$26B
| $1.68M | ﹤0.01% |
43,400
-34,800
| -45% | -$1.38M |
2020 Q2
11 quarters
|
|
3500
Atlanta Braves Holdings Series B
BATRK
$3.34B
| $1.68M | ﹤0.01% |
49,726
+2,023
| +4% | +$68.1K |
2016 Q2
27 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.